Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 13/20 | 0.53 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.39 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | DRD4 | P21917 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.36 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.35 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3435656 | 1.00 | SLC6A9 (0.53) | SLC6A9C5AR1DRD2DRD4MEN1 | |
| SCHEMBL3436282 | 0.86 | SLC6A9 (0.53) | SLC6A9C5AR1DRD2DRD4SIRT2 | |
| SCHEMBL3436283 | 0.86 | SLC6A9 (0.53) | SLC6A9C5AR1DRD2DRD4SIRT2 | |
| SCHEMBL3434159 | 0.82 | SLC6A9 (0.49) | SLC6A9C5AR1MEN1KMT2ASIRT2 | |
| SCHEMBL3436233 | 0.82 | SLC6A9 (0.49) | SLC6A9C5AR1MEN1KMT2ASIRT2 | |
| SCHEMBL3435588 | 0.76 | HDAC1 (0.40) | DRD2DRD4SIRT2SIRT1TLR8 | |
| SCHEMBL3435649 | 0.75 | MEN1 (0.45) | DRD2MEN1USP2GAAKMT2A | |
| SCHEMBL5995588 | 0.66 | SLC6A9 (1.00) | SLC6A9 | |
| SCHEMBL5995583 | 0.66 | SLC6A9 (1.00) | SLC6A9 | |
| SCHEMBL5996602 | 0.65 | SLC6A9 (1.00) | SLC6A9DRD2DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8163746-B2 | Azolecarboxamide derivative | ASTELLAS PHARMA INC. (JP) | 2012-04-24 | — | — | US | disclosed |
| US-20090286766-A1 | AZOLECARBOXAMIDE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286766-A1 | AZOLECARBOXAMIDE DERIVATIVE | GPR17, NTRK1, TRPV1 | SLC6A9 3516/4885C5AR1 1309/4885DRD2 3571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.